To systematically explore the CHI3L2 protein expression in diffusely infiltrating glioma, we first evaluated the CHI3L2 expression levels of 288 glioma tissues by immunohistochemistry (IHC) and analyzed the association between CHI3L2 levels and clinicopathological parameters. The gene discussed is CHI3L2; the disease is central nervous system cancer.